TD-1058
0185
Phase 1 small_molecule terminated
Quick answer
TD-1058 for Idiopathic Pulmonary Fibrosis (IPF) is a Phase 1 program (small_molecule) at Theravance Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Theravance Biopharma
- Indication
- Idiopathic Pulmonary Fibrosis (IPF)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated